REG - Polar Cap Glb Health PCGH ZDP PLC - Result of AGM

Polar Capital Global Healthcare TrustAnnouncement

09/02/2023 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230209:nRSI4952Pa&default-theme=true

RNS Number : 4952P  Polar Capital Global Health Tst PLC  09 February 2023

Polar Capital Global Healthcare Trust plc ("the Company")

Legal Entity Identifier: 549300YV7J2TWLE7PV84

 

Results of the Company's 12(th) Annual General Meeting ("AGM")

held at 2pm on Thursday 9 February 2023

 

All the resolutions proposed at the Annual General Meeting of the Company were
voted on and passed on a poll. The resolutions proposed at the AGM can be
found in the Notice of AGM which is available on the Company's website.

The following table indicates the number of proxy votes lodged in advance of
the meeting for each of the resolutions. It should be noted that votes
withheld do not constitute votes in law. As at the date of the AGM, the
Company's issued share capital consisted of 124,149,256 Ordinary shares of 25p
each. The Company holds 2,879,256 Ordinary shares in treasury. Therefore, the
total voting rights in the Company is 121,270,000; 53.2% of the voting rights
were cast by proxy.

In accordance with Listing Rule 9.6.2, copies of resolutions 12 and 13 (having
been passed as special resolutions), will be submitted to the National Storage
Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

 Resolution                                                                     In favour   Against  Withheld
 1.    To receive the Annual Report and Financial Statements for the year       64,635,448  0        5,228
 ended 30 September 2022

 2.    To receive and approve the Directors' Remuneration Policy                64,609,620  10,065   20,991
 3.    To approve the Directors' Remuneration Implementation Report for the     64,607,975  10,065   22,636
 year ended 30 September 2022

 4.    To re-elect Lisa Arnold as a Director                                    63,901,192  722,556  16,928

 5.    To re-elect Neal Ransome as a Director                                   63,904,737  719,011  16,928

 6.    To re-elect Andrew Fleming as a Director                                 63,904,737  719,011  16,928

 7.    To re-elect Jeremy Whitley as a Director                                 63,904,737  719,011  16,928

 8.    To re-appoint PricewaterhouseCoopers LLP as auditors                     64,623,266  482      16,928

 9.    To authorise the Directors to determine the auditors' remuneration       64,623,276  472      16,928

 10.  To approve the Company's Dividend Policy                                  64,619,548  4,200    16,928

 11.  To authorise the allotment of ordinary shares                             64,624,764  9,184    6,728

 12.  To disapply pre-emption rights                                            64,566,178  34,270   40,228

 13.  To grant the Company authority to buy back its own ordinary shares        64,634,448  1,000    5,228

 

 

Enquiries:

Tracey Lago, FCG

Polar Capital Global Healthcare Trust plc

020 7227 2700

https://www.polarcapitalhealthcaretrust.com
(https://www.polarcapitalhealthcaretrust.com)

 

 

9 February 2023

 

 

Neither the contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other website) is
incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSSDFIUEDSEEE